Overview

Mayo Clinic's RNA Therapeutics Discovery and Translation Program is positioned to become a global leader in RNA-driven cures.

The program researches, develops, validates and applies therapeutics across various disease areas, including neurological diseases, cancer and rare diseases. It provides education and leverages internal and external collaborations to:

• Discover and design RNA-based therapeutic candidates.
• Develop reliable and scalable RNA manufacturing methods.
• Prepare therapies for translation beyond the laboratory.
• Test safety and effectiveness of therapies in clinical studies.

Advisory board

The program's External Advisory Board provides expert guidance and stakeholder input that informs the strategic direction, priorities and impact of the program. The board advises on program goals, identifies opportunities and risks, recommends best practices, and supports stakeholder engagement to advance the program's vision.